Living evidence-informed guideline on the early detection of oral squamous cell carcinoma
Originally at sciencedirect.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
JADA has published a living clinical practice guideline that gives dentists an evidence-based algorithm for using salivary adjunct tests to decide whether a suspicious oral lesion needs biopsy; practices that routinely screen for oral cancer must now decide whether to integrate the recommended tests to reduce missed malignancies and unnecessary biopsies.
Key points
- Guideline Version 2026 1.0, available online 28 September 2026, addresses salivary adjunct tests for oral squamous cell carcinoma and potentially malignant disorders.
- Authored by an international multidisciplinary panel including oral medicine, pathology, public-health, and patient-advocacy representatives.
- Focus is on determining biopsy necessity, directly affecting diagnostic protocols in general, oral-medicine, and oral-surgery practices.
- Because it is labeled a “living” guideline, future updates will be issued as new evidence emerges; clinicians should monitor JADA for revisions.
Who should care
Read the original on Journal of the American Dental Association (JADA)
Full reporting and any paywall content live on sciencedirect.com. We summarize and score; we do not republish.
Related
- ·Regulatory
Dental manager charged with a dozen-plus felonies
- ·Regulatory
Suleman Nasimi, dentist from Hicksville practicing in Queens, charged with stealing more than $300,000 from Medicaid
- ·Regulatory
Dentist from Hicksville charged with stealing $300K from Medicaid
- ·Regulatory
As Medicaid Budgets Tighten, What Happens to Adult Dental Benefits?